TABLE 4.
Outcome | Model | Treatment(s) and control | Endotoxin | Inflammatory markers included | Reference |
---|---|---|---|---|---|
High-saturated fat diet increased proportion of gram-negative gut microbiomes and increased endotoxemia | C57BL/6J mice | Control—standard murine dietTreatment—72% energy from fat (corn oil and lard), 28% energy from protein, and >1% energy from carbohydrate | ↑2 | TNF↑, IL-1↑, IL-6↑, plasminogen activator inhibitor↑ | Cani et al. (20) |
Chronic high-saturated fat diet increased metabolic endotoxemia | C57BL/6, Myd88−/−, Trif−/−, Tlr4−/−, and Tlr2−/− mice | Treatments—45% of energy from fish oil or lard | ↑2 | TNF↑ | Caesar et al. (23) |
Saturated fat increased postprandial endotoxemia and treatment of ileal epithelium increased permeability to LPS | Pig | Control—porridge made with 50 mL waterTreatments—porridge made with 50 mL of fish oil, vegetable oil, or coconut oil | ↑3 | None | Mani et al. (24) |
Arabinoxylan supplementation resulted in less fat mass development, better insulin sensitivity, greater gut integrity, less endotoxemia, less inflammation, a bloom of Bifidobacterium, cecal and colon enlargement, and an increase in colonic expression of genes related to SCFA response | C57BL/6J mice | Control—high-fat (60% of energy)Treatment—high-fat diet supplemented with 7.5% (wt:wt) arabinoxylan extract | ↓2 | TNF↔, IL-1↔, IL-6↓, monocyte chemoattractant protein↔ | Neyrinck et al. (93) |
LAL, Limulus amebocyte lysate; ↑, increase; ↓, decrease; ↔, even.
Measured using the LAL assay.
Assessed using the PyroGene rFC Assay, Lonza, Switzerland.